alexa Antibiotic Susceptibility Surveillance of Environmental Legionella Strains: Application of the E-Test to Bacteria Isolated From Hospitals in Greece. | OMICS International | Abstract
ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

Antibiotic Susceptibility Surveillance of Environmental Legionella Strains: Application of the E-Test to Bacteria Isolated From Hospitals in Greece.

Ioanna G. Alexandropoulou1,2, Theodoros A. Parasidis1,2*, Theocharis G. Konstantinidis1,2, Theodoros C. Constantinidis3
and Maria Panopoulou1
1Microbiology Laboratory, Medical School, Democritus University of Thrace, Alexandropoulos, Greece
2Regional Public Health Laboratory (East Macedonia-Thrace), Hellenic Centre for Disease Control and Prevention, Alexandropoulos, Greece
3Laboratory of Hygiene and Environmental Protection, Medical School, Democritus University of Thrace, Alexandropoulos, Greece
Corresponding Author : Theodore A Parasidis
Biologist, Microbiology Laboratory
Medical School, Democritus University of Thrace
Preclinical Courses Buildings, Campus, Medical school, Greece
Tel/Fax: 302551075154
E-mail: [email protected]
Received December 01, 2013; Accepted December 03, 2013; Published December 10, 2013
Citation: Alexandropoulou IG, Parasidis TA, Konstantinidis TG, Constantinidis TC, Panopoulou M (2013) Antibiotic Susceptibility Surveillance of Environmental Legionella Strains: Application of the E-Test to Bacteria Isolated From Hospitals in Greece. J Infect Dis Ther 1:e103. doi: 10.4172/2332-0877.1000e103
Copyright: © 2013 Alexandropoulou IG, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google

Abstract

Legionella bacteria are the causative agent of legionellosis, an infection mainly acquired through aspiration of contaminated water. Macrolides and flouroquinolones are the treatment of choice for legionellosis. The selection of these categories is mainly based on clinical experience. Especially erythromycin was the first line drug in the treatment of legionellosis, even though erythomycin resistant strains can easily be obtained in vitro. Flouroquinolones has been shown to succeed high intracellular inhibition of Legionella compared with erythromycin

Keywords

Recommended Conferences
Share This Page
Top